BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 27444109)

  • 1. Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas.
    Han Y; Zhang Q; Yu X; Han X; Wang H; Xu Y; Qiu X; Jin F
    Int J Clin Exp Pathol; 2015; 8(10):13166-75. PubMed ID: 26722515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Clinicoradiological Poorly Recognized Entity- An Institutional Experience.
    Sahoo N; Mohapatra D; Panigrahi S; Lenka A; DAS P; Mohapatra SS
    Turk Neurosurg; 2020 Nov; ():. PubMed ID: 34374969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of Extraneural Metastases of Nonhematolymphoid Primary Central Nervous System Tumors: Six Cases with Histopathological Correlation and Literature Update.
    Schwock J; Mirham L; Ghorab Z
    Acta Cytol; 2021; 65(6):529-540. PubMed ID: 34311461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial Hemangiopericytomas: Recurrence, Metastasis, and Radiotherapy.
    Patel AR; Flores BC; Ban VS; Hatanpaa KJ; Mickey BE; Barnett SL
    J Neurol Surg B Skull Base; 2017 Aug; 78(4):324-330. PubMed ID: 28725519
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of recurrent giant hemangiopericytoma: illustrative cases.
    Vignolles-Jeong J; Finger G; McGahan BG; Beaumont TL; Weber MD; Wu KC; Prevedello DM
    J Neurosurg Case Lessons; 2024 Mar; 7(13):. PubMed ID: 38531083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification for Management of Solitary Fibrous Tumor/Hemangiopericytoma of the Central Nervous System.
    Kinslow CJ; Rae AI; Kumar P; McKhann GM; Sisti MB; Bruce JN; Yu JB; Cheng SK; Wang TJC
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading of meningeal solitary fibrous tumors/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132 patients.
    Macagno N; Vogels R; Appay R; Colin C; Mokhtari K; ; ; Küsters B; Wesseling P; Figarella-Branger D; Flucke U; Bouvier C
    Brain Pathol; 2019 Jan; 29(1):18-27. PubMed ID: 29600523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.
    Kinslow CJ; Bruce SS; Rae AI; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sonabend AM; Wang TJC
    J Neurooncol; 2018 May; 138(1):173-182. PubMed ID: 29427152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.
    Jeon SH; Park SH; Kim JW; Park CK; Paek SH; Kim IH
    J Neurooncol; 2018 May; 137(3):567-573. PubMed ID: 29327171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.
    Kinslow CJ; Rajpara RS; Wu CC; Bruce SS; Canoll PD; Wang SH; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Wang TJC
    J Neurooncol; 2017 Jun; 133(2):409-417. PubMed ID: 28447278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution.
    Zhu H; Duran D; Hua L; Tang H; Chen H; Zhong P; Zheng K; Wang Y; Che X; Bao W; Wang Y; Xie Q; Gong Y
    World Neurosurg; 2016 Jun; 90():414-419. PubMed ID: 26960287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis.
    Yamashita D; Suehiro S; Kohno S; Ohue S; Nakamura Y; Kouno D; Ohtsuka Y; Nishikawa M; Matsumoto S; Bernstock JD; Harada S; Mizuno Y; Kitazawa R; Ohnishi T; Kunieda T
    Neurosurg Rev; 2021 Jun; 44(3):1591-1600. PubMed ID: 32671693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Solitary fibrous tumor/hemangiopericytoma of central nervous system: a clinicopathologic analysis of 71 cases].
    Li XL; Fu WW; Zhang S; Chen DY; Chen YP; Wu J; Liu XY; Li GP; Lin SM; Luo S; Cai SS; Guo W; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):465-470. PubMed ID: 28728219
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    Bertero L; Anfossi V; Osella-Abate S; Disanto MG; Mantovani C; Zenga F; Rudà R; Garbossa D; Soffietti R; Ricardi U; Papotti M; Cassoni P
    PLoS One; 2018; 13(9):e0203570. PubMed ID: 30183767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemangiopericytomas in the Central Nervous System: A Multicenter Study of Korean Cases with Validation of the Usage of STAT6 Immunohistochemistry for Diagnosis of Disease.
    Choi J; Park SH; Khang SK; Suh YL; Kim SP; Lee YS; Kwon HS; Kang SG; Kim SH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):954-961. PubMed ID: 27444109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningeal solitary fibrous tumor/hemangiopericytoma: Emphasizing on STAT 6 immunohistochemistry with a review of literature.
    Ahmad Z; Tariq MU; Din NU
    Neurol India; 2018; 66(5):1419-1426. PubMed ID: 30233017
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.